Literature DB >> 19246336

Flax lignan complex slows down the progression of atherosclerosis in hyperlipidemic rabbits.

Kailash Prasad1.   

Abstract

Flax lignan complex suppresses the development of hypercholesterolemic atherosclerosis. However, it is not known whether flax lignan complex would slow down the progression of hypercholesterolemic atherosclerosis. This study was carried out to determine whether flax lignan complex slows down the progression of already developed atherosclerosis, and whether this effect is associated with reductions in serum lipids and oxidative stress. The studies were conducted in 4 groups of rabbits: group I, regular diet (2 months); group II, 0.25% cholesterol diet (2 months); group III, 0.25% cholesterol diet (4 months); group IV, 0.25% cholesterol diet (2 months) followed by 0.25% cholesterol diet plus flax lignan complex (2 months). Serum lipids and oxidative stress parameters (malondialdehyde, antioxidant reserve, white blood cell chemiluminescence) were measured before and at monthly intervals thereafter on their respective diets. Aortas were removed at the end of the protocol for assessment of atherosclerosis and oxidative stress. Atherosclerosis in group II was associated with hyperlipidemia and increased oxidative stress. Significant areas of the aortic intimal surfaces from group II (37.76% + 7.96%), group III (76.6% + 9.04%), and group IV (52.95% + 10.29%) were covered with atherosclerotic plaques. Group IV rabbits had 40% more atherosclerotic lesions than group II but 31% fewer lesions than group III. The flax lignan complex-induced reduction in the progression of atherosclerosis was associated with reductions in oxidative stress. In conclusion, flax lignan complex was effective in slowing down the progression of atherosclerosis by 31%, and this effect was associated with a reduction in oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246336     DOI: 10.1177/1074248408330541

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  9 in total

Review 1.  Flaxseed and Its Components in Treatment of Hyperlipidemia and Cardiovascular Disease.

Authors:  Kailash Prasad; Amal S Khan; Muhammad Shoker
Journal:  Int J Angiol       Date:  2020-04-14

2.  Vitamin E does not slow the progression of hypercholesterolemic atherosclerosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2009

Review 3.  Flaxseed for hypertension: implications for blood pressure regulation.

Authors:  Stephanie P B Caligiuri; Andrea L Edel; Michel Aliani; Grant N Pierce
Journal:  Curr Hypertens Rep       Date:  2014-12       Impact factor: 5.369

4.  Vitamin E slows the progression of hypercholesterolemia-induced oxidative stress in heart, liver and kidney.

Authors:  Kailash Prasad; Erick D McNair; A Mabood Qureshi; Gudrun Casper-Bell
Journal:  Mol Cell Biochem       Date:  2012-06-20       Impact factor: 3.396

Review 5.  Current Status of Primary, Secondary, and Tertiary Prevention of Coronary Artery Disease.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2021-08-25

6.  Effects of vitamin E on serum enzymes and electrolytes in hypercholesterolemia.

Authors:  Kailash Prasad
Journal:  Mol Cell Biochem       Date:  2010-02       Impact factor: 3.396

Review 7.  Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets.

Authors:  S Franklyn De Silva; Jane Alcorn
Journal:  Pharmaceuticals (Basel)       Date:  2019-05-05

Review 8.  Biomedical features of flaxseed against different pathologic situations: A narrative review.

Authors:  Babak Ebrahimi; Zohreh Nazmara; Negar Hassanzadeh; Atousa Yarahmadi; Neda Ghaffari; Fatemeh Hassani; Amirreza Liaghat; Leila Noori; Gholamreza Hassanzadeh
Journal:  Iran J Basic Med Sci       Date:  2021-05       Impact factor: 2.699

Review 9.  Potential protective properties of flax lignan secoisolariciresinol diglucoside.

Authors:  Muhammad Imran; Nazir Ahmad; Faqir Muhammad Anjum; Muhammad Kamran Khan; Zarina Mushtaq; Muhammad Nadeem; Shahzad Hussain
Journal:  Nutr J       Date:  2015-07-28       Impact factor: 3.271

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.